10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Operating activities | |||
| Net income | $ 3,750 | 3,843 | 2,470 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized losses (gains) on financial instruments | 180 | (145) | (5) |
| Other-than-temporary impairment losses recognized in income | 26 | 33 | 115 |
| Loss on extinguishment of debt | 11 | 282 | 0 |
| Loss on disposal of assets | 8 | 13 | 5 |
| Deferred income taxes | 91 | (1,272) | 127 |
| Amortization, net of accretion | 1,008 | 780 | 808 |
| Depreciation expense | 124 | 111 | 104 |
| Impairment of property and equipment | 5 | 2 | 45 |
| Share-based compensation | 226 | 170 | 165 |
| Excess tax benefits from share-based compensation | 0 | 0 | (54) |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (695) | (22) | (1,381) |
| Other invested assets | (1) | (36) | (19) |
| Other assets | (26) | (629) | (128) |
| Policy liabilities | (1,059) | 732 | 322 |
| Unearned income | (36) | (120) | (174) |
| Accounts payable and accrued expenses | 122 | 922 | 182 |
| Other liabilities | (25) | (120) | 606 |
| Income taxes | 323 | (194) | 179 |
| Other, net | (205) | (165) | (97) |
| Net cash provided by operating activities | 3,827 | 4,185 | 3,270 |
| Investing activities | |||
| Purchases of fixed maturity securities | (8,244) | (9,795) | (10,158) |
| Proceeds from fixed maturity securities: | |||
| Sales | 6,442 | 7,932 | 8,636 |
| Maturities, calls and redemptions | 1,938 | 1,848 | 1,419 |
| Purchases of equity securities | (896) | (5,416) | (1,476) |
| Proceeds from sales of equity securities | 2,809 | 3,463 | 1,593 |
| Purchases of other invested assets | (531) | (1,164) | (433) |
| Proceeds from sales of other invested assets | 411 | 219 | 305 |
| Changes in collateral and settlement of non-hedging derivatives | 0 | 65 | (35) |
| Changes in securities lending collateral | (149) | 625 | 222 |
| Purchases of subsidiaries, net of cash acquired | (1,760) | (2,080) | 0 |
| Purchases of property and equipment | (1,208) | (800) | (584) |
| Proceeds from sales of property and equipment | 0 | 9 | 0 |
| Other, net | (71) | 12 | (3) |
| Net cash used in investing activities | (1,259) | (5,082) | (514) |
| Financing activities | |||
| Net (repayments of) proceeds from commercial paper borrowings | (107) | 175 | (53) |
| Proceeds from long-term borrowings | 835 | 5,458 | 0 |
| Repayments of long-term borrowings | (1,684) | (2,815) | 0 |
| Proceeds from short-term borrowings | 9,120 | 5,835 | 2,400 |
| Repayments of short-term borrowings | (9,250) | (5,000) | (2,500) |
| Changes in securities lending payable | 150 | (625) | (222) |
| Changes in bank overdrafts | (210) | 71 | 513 |
| Proceeds from sale of put options | 1 | 1 | 0 |
| Proceeds from issuance of common stock under Equity Units stock purchase agreements | 1,250 | 0 | 0 |
| Repurchase and retirement of common stock | (1,685) | (1,998) | 0 |
| Change in collateral and settlements of debt-related derivatives | 23 | (149) | (360) |
| Cash dividends | (776) | (705) | (684) |
| Proceeds from issuance of common stock under employee stock plans | 173 | 225 | 120 |
| Taxes paid through withholding of common stock under employee stock plans | (81) | (46) | (67) |
| Excess tax benefits from share-based compensation | 0 | 0 | 54 |
| Net cash (used in) provided by financing activities | (2,241) | 427 | (799) |
| Effect of foreign exchange rates on cash and cash equivalents | (2) | 4 | 5 |
| Change in cash and cash equivalents | 325 | (466) | 1,962 |
| Cash and cash equivalents at beginning of year | 3,609 | 4,075 | |
| Cash and cash equivalents at end of year | 3,934 | 3,609 | 4,075 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |